Ingersoll Rand Inc. (IR) Earnings Call Transcript & Summary

September 10, 2026

NYSE US Industrials Machinery conference_presentation 34 min

What were the key takeaways from Ingersoll Rand Inc.'s September 10, 2026 earnings call?

Ingersoll Rand Inc. reported a positive outlook for Q3 2026, with management highlighting a resurgence in both short and long cycle orders. Revenue growth is expected to be driven by a mid-single-digit increase in short-cycle orders and a recovery in long-cycle projects, with management expressing optimism about the momentum in these segments. The company maintained its guidance for the fiscal year, with expectations for improved margins in the second half, supported by pricing actions and volume recovery. Q2 revenue figures were not disclosed, but management indicated a healthy trajectory moving forward.

What topics did Ingersoll Rand Inc. cover?

  • Short Cycle Orders Growth: Management reported a mid-single-digit increase in short-cycle orders, particularly in North America, which was described as the 'strongest contributor' to this growth. Vikram Kini noted, 'we're very encouraged to now start to see better momentum not just on the short to medium cycle side, but also on the long cycle side.'
  • Long Cycle Orders Recovery: After a prolonged period of decision-making delays, management indicated that long-cycle projects are finally coming to fruition. Kini stated, 'the long-cycle funnel continues to remain active and relatively healthy,' suggesting a positive shift in customer decision-making.
  • Margin Improvement Expectations: Management expressed confidence in margin recovery, citing targeted pricing actions and improved volume as key drivers. Kini stated, 'we would expect a healthier margin profile as we exit the back half of this year.'
  • China Market Dynamics: Management acknowledged a decline in revenue contribution from China, which has dropped from 15% to 10%. However, they noted 'low double-digit revenue growth in China' in Q2, indicating a potential recovery in this market.
  • Recurring Revenue Growth: Ingersoll Rand is targeting $1 billion in recurring revenue, up from $450 million last year. Kini emphasized that this growth is driven by multiyear contracts and aftermarket services, which are expected to bolster margins.

What were Ingersoll Rand Inc.'s September 10, 2026 results?

  • Revenue Growth: (Management indicated mid-single-digit growth in short-cycle orders.)
  • Long Cycle Orders: (Management noted a recovery in long-cycle projects.)
  • Margins: 26-27% (Current margins in ITS, with expectations for improvement in the second half.)
  • Recurring Revenue Target: $1B (Target up from $450 million last year.)
  • China Revenue Contribution: 10% (Down from 15%, but showing low double-digit growth in Q2.)
  • M&A Transactions Under LOI: 11 (Indicates active M&A activity.)

Ingersoll Rand's positive momentum in both short and long cycle orders, along with a strong focus on recurring revenue, positions the company favorably for future growth. Investors should monitor the recovery in China and the effectiveness of margin improvement strategies as key catalysts for stock performance.

Earnings Call Speaker Segments

Stephen Volkmann

analyst
#1

All right. Welcome, folks. I'm Steve Volkmann with Jefferies and very pleased to be hosting Ingersoll Rand for this fireside chat. Vik Kini, the CFO, has joined us. And we're going to run this as a fireside chat. So I'll probably lead off with a few questions, but would love to have your participation as well. If you're interested, we have a mic that will make a come up for air at some point and see if we have any questions from the field.

Stephen Volkmann

analyst
#2

But Vik, I've been asking this question, you can answer as quickly or long as you would like. But since we are on a webcast, I figured I would just provide the opportunity if there's any updates or thoughts around how Q3 is progressing that you'd like to share, we'd love to hear them.

Vikram Kini

executive
#3

Yes, sure. So first of all, thanks for having us, and great to be here as always. I think simply stated here, obviously, nothing we're providing actually incremental around initially August or September or anything like that further than what we spoke about on our earnings call. But I'll reiterate some of the statements we made in Q2 at our earnings call because we did provide a little bit more color, particularly around July. I think the piece that we'd kind of lean on here is that in Q2, encouraged to see kind of some of that short medium cycle side of the business starting to kind of come back a little bit more. I think within ITS, you saw about mid-single-digit orders increase on the short to medium cycle side, which is kind of the call it a core bread and butter side of the equation with not surprising North America probably being the strongest contributor here on the orders front. In Q2, we did mention that some of the timing of some of the longer cycle was kind of a headwind that kind of sat on top of that, which is what brought ITS orders more flattish from an organic perspective. And we provided the color in our earnings call with the benefit of city towards the end of July, we had kind of 4 weeks of July behind us. And as you know, it's not our norm to initially give intraquarter orders, updates and things like that. But we thought it was important to provide a little bit of color that we had seen in the first number of weeks of July, low double digit to mid-teens orders improvement on the ITS front. And the best way I'd probably describe that here is comparable trajectory on the short to medium cycle that you saw in Q2. But the piece, obviously, that was encouraging on incremental to that was the long cycle piece. We've been talking for the better part of 18 to 24 months that long cycle, the funnel continues to remain active and relatively healthy, but you had seen kind of the elongation of decision-making from customers for a number of reasons. And as such, that had led to some, I'd say, lower, I'd say, orders front on the long cycle, they would have historically seen over that time frame. July, you did see a number of those projects finally come to fruition. So I think the good news here is, one, July is just 1 data point, but we're very encouraged to now start to see better momentum not just on the short to medium cycle side, but also on the long cycle side. Obviously, all of this lends itself to in the volume side of the equation, which is the piece that kind of the bigger headwinds on over the last 2 years. So again, encouraged by what we're seeing here. We'll continue to track and monitor this as we obviously and give you guys obviously appropriate color here as we get through earnings. But encouraged, I think, for the first time in a couple of years to really start seeing kind of both sides of the equation, starting to move in the positive direction, which is definitely encouraging from us -- from our front.

Stephen Volkmann

analyst
#4

Great. So a couple of quick follow-ups just because everybody might not be deep in the weeds here. How do you think about the breakdown between your short cycle and long cycle?

Vikram Kini

executive
#5

For sure. Yes. So I'll talk to the lens of ITS, which is our largest segment, about 80% of the revenue of the company. So let me just start by saying business composition is -- I'll use rough numbers, 35% to 40% aftermarket. Aftermarket, obviously, is much more, I'd say, utilization base based on our equipment and things of that nature. When you park that, you have the other, let's call it, 60%, 65% that is original equipment. And that is broken down approximately 75% is kind of short to medium cycles. So I would call it core compressor blower, vacuum type technology, kind of the bread and butter, if you will, typically somewhere between 30-, 90-day type lead times, pretty tight book ship type business, but kind of the core. And then the balance, which would be the remaining 25% is longer cycle in nature. And the way to kind of think about longer cycle, you might hear us refer to it as ETO or systems or projects. They typically are larger scale projects in nature, predicated around the technology and then typically larger systems or skids or things like that built out customized for our respective customer base. And they're typically anywhere from 0.5 million, but typically 7-figure type price tags, 6 to 18 months in terms of duration, meaning from when the order is taken to final shipment. And obviously, the larger the sticker price typically the duration. So that's probably the best way to think about the composition, particularly with an ITS. Also worth noting that on the PST side, the Precision Technologies business, the core pumping business, which is about the larger piece of that equation, that also has a fairly similar exposure to our long-cycle projects as well in some of our pumping and dosing type technologies.

Stephen Volkmann

analyst
#6

Okay. So short cycle, up mid-single digits, I think, in the 2Q. What really drove that after this kind of long wait?

Vikram Kini

executive
#7

Yes, I think it's -- like you've seen kind of in the broader -- obviously, with PMI is continuing to improve I think you're seeing now our portfolio, which core industrial, compression, blower technology, vacuum technology, pump technology, it's kind of mission-critical from a process perspective. And so you're seeing it kind of broad based. I wouldn't point to one specific end market. I think what you've seen over the last few years is, I talk by region, you've obviously seen a couple of years of headwinds from a North America perspective, particularly from areas like some of the tariff-related impact you saw last year and then some of the items that from administration changes provided to that, things like neural natural gas that kind of had a peak back in the '24 time frame. And obviously, you kind of came back down, back in '25. China similar. China used to be about 15% of the revenue base of the company. Today, it's close to 10%. And Europe has actually been kind of the most stable business kind of in between over the last few years. So I think some of the just kind of inherent macro recovery you're seeing, you're seeing, obviously, not surprisingly, North America and Asia, particularly China, starting to see better traction. And that's exactly like we said, we saw in Q2 with the short to medium cycle being up mid-single digits, with -- but North America being the leader of the pack there at up high single digit on the order's front. So again, encouraged to see kind of that, I'd say, regular kind of I'd say industrial activity starting to come back. You're seeing it obviously in the short to medium cycle side. And then we've obviously talked about the long cycle side, starting to finally see some better traction on the orders front.

Stephen Volkmann

analyst
#8

So I was going to go to long cycle next. So we've had some delays on some big projects. Those seem to be starting to loosen up -- is this more sort of a timing issue? Or do you think there's a broadening of demand there as well.

Vikram Kini

executive
#9

Yes, the way we'd probably describe it here is kind of go back to how we characterize it. The long-cycle funnel had been relatively active and healthy. Yes, you've definitely seen an elongation in terms of just customers decision-making patterns to actually kind of ink the final PO, but one of the big things and frankly, some of the reasons that we wanted to provide a little bit of that July commentary is inherently, the question becomes if you see delays that ultimately led to cancellations of these projects. And that's not the case. . If you actually look at our product portfolio, you actually have long-cycle exposure across all of our core technologies, compressor, blower, vacuum and pump. And it's actually a fairly widespread from a geographic -- so it's not hypercenterc, or region. It's actually pretty widespread. And even in July, again, it wasn't just like 1 or 2 big projects. It was actually a number of the kind of more call it, single-digit millions of dollar type projects coming to fruition actually well spread from a geographic and end market perspective. So I think what we'd say here is I can't point to necessarily one single bullet. Silver bullet is like here is the reason. I think we would attribute it a little bit more to timing and just some of the customer decision making, but it also does speak to those projects valid, we're always going to get -- continue to move forward and now finally starting to see a little bit of unlock. But I think the other piece that's encouraging is the long-cycle funnel in general continues to be active. It's not like you're seeing a big flush and there isn't, I'd say activity backfilling and we're actually seeing good quoting activity continuing within the funnel, which is encouraging.

Stephen Volkmann

analyst
#10

Great. Okay. The other thing that's been topical this last couple of days here is a lot of kind of cost volatility, whether it's metals or energy or transportation and just sort of bring us up to speed on kind of how you're seeing that play out?

Vikram Kini

executive
#11

Yes. So I mean I think like anyone, we're seeing requisite pockets here and there. Now let's characterize who we are and who we not. We're not like heavy manufacturing. We are essentially assembly. So we're not buying raw commodities or anything like that. We're buying much more semi-finished goods and things of that nature. So obviously, I think we're managing that piece as you would expect. I think at this point in time, pricing, I think, from our end, has kind of come back into that typical norm of 1% to 2% that you typically see, I'd say, in a given year. Now obviously, the last number of years, you've seen elevated pricing levels due to tariffs and some of the supply chain disruption. So I think we're continuing to manage that at this point in time. We'll continue to evaluate as we go forward here. I think the teams are doing a good job managing that within expectations, but nothing I would call out as dramatically out of source at this point in time.

Stephen Volkmann

analyst
#12

Okay. And so for the second half, we're assuming price/cost neutrality.

Vikram Kini

executive
#13

Neutrality to slightly better. Yes, I think we expect it to be improving from the first half into the second half. We have taken some pricing actions on half that would expect to kind of materialize in the back half. To your point, we'll continue to monitor what's going on in a pretty fluid environment. But yes, I think -- the last few years, you obviously have seen, particularly with the tariff side, you've seen price/cost be neutral, but obviously margin dilutive. I think we're slowly surely growing out of that. And I think as we move into next year and the year after, we would expect pending what may or may not happen there. We expect that to return back to a slightly better margin equation compared to what you've seen in the last few years.

Stephen Volkmann

analyst
#14

Okay. All right. Maybe let's open up the aperture a little bit. Investors keep asking about AI exposure. It depends on what day they ask whether that's a good thing or a bad thing. But talk about how compressors, vacuum blowers, pumps fit into data center and power gen and sort of that theme.

Vikram Kini

executive
#15

Yes, for sure. So I think to date, our direct AI exposure -- data center exposure has been relatively minimal as you've seen. It's probably fair to say maybe second derivative impacts of some of the providers. We obviously are providing our air compression technology in process-driven equipment for their manufacturing needs and things of that nature. Now that being said, probably over the last year or so, we have spent, I'd say, more time internally really from an organic perspective, thinking about how we can maybe play a little bit more in the data center realm to keep it simple here. When you think about air compression technology pumps, things that move air gas and liquid for cooling purposes or other purposes, we do feel like there is applicability there. I would say, also bundled with one of our core competencies is our engineering capabilities and ETO capabilities. So ETO or long cycle. Like we said, 25% of our original equipment is long cycle or ETO in nature. And we do believe that with some of the trends that we're seeing there with some of these larger hyperscalers or data center manufacturers, that is a capability they want to see. So I think simplest way to say it right now, Steve, is right now, is it very material in the Ingersoll Rand revenue perspective, not today. Do we feel like on the go forward, there are opportunities for us to play a little bit more tangibly in the space and that we're actively working with some of these customers to actually be able to show off showcase not just some of our technology, but then also our ETO capabilities, yes. So I think there are some opportunities and pockets that we're looking to target across our core technology on a go-forward basis.

Stephen Volkmann

analyst
#16

Okay. What about semiconductor is another focus. And I know your big competitor has more exposure there. But is that a target for you as well?

Vikram Kini

executive
#17

So we do have on the compressor side, I'd say, selling larger health compression technology for air separation, things like that, which plays into the semiconductor kind of value chain. From a direct, what I'll call the vacuum perspective, I think was your question here. No, we don't play on the -- what I'll call the high vacuum side of vacuum. We play much more on what we call the rough industrial process vacuum. So it's much more of the industrial or kind of non-semiconductor type applications. That's where we've historically played. So and I don't think you're going to see that really change going forward. So the direct semis exposure on vacuum that you're referencing no, that's not part of our vacuum portfolio. .

Stephen Volkmann

analyst
#18

Okay. Maybe we'll do a little geographic discussion. You mentioned China has gone from 15% to 10% of revenue. Describe what happened there for those that might not be as close to it. And then, of course, outlook what's the outlook?

Vikram Kini

executive
#19

For sure. Yes. So if you flash back a couple of years, let's go find really back to the 2020 post merger, kind of until '23-'24 time frame. Obviously, China was closer to 15% of our total company revenue. I think you saw 1 just based on the markets there, but then also you saw areas like EV battery and photovoltaic and solar type application. You saw a big run-up in that market. If you've been to China, I mean, you can see it there, with your own eyes. And a lot of our core compression technology plays well in that space. So what you saw kind of post that time frame, whether '24 to '25 is not surprisingly, you saw obviously with the EV batteries and some of that kind of coming back down. You saw -- I'll use rough numbers, roughly about $100 million headwind as that kind of reset back to normalized levels, then combined with obviously some of the challenges seen in the general China kind of market. And so you kind of flash forward now to kind of where we are today, China is closer to approximately 10% of revenue from a total company perspective. As we sit here right now, though, I think we're encouraged by -- after about 2 years of the China business kind of leveling out, for lack of a better way, say it, we have seen, I'd say, kind of I'd say, healthier volume here as we've sat here into the first half. In second quarter, just an example, we saw low double-digit revenue growth in China, and that's really all volume driven. So I think we're encouraged to finally start to see some return to kind of, I'd say, hopefully, some normalization on the growth front in China. I think if you think about where our business plays in China, Ingersoll Rand's presence in China historically has been very compressor centric. That's really where it space was. Obviously, that team has done an incredible job bringing in, and I'd say, leveraging technology is that they historically didn't have as much access to. And what I mean by that is what came as part of the merger that the legacy IR China franchise didn't have. That would be product technologies like blower and vacuum which came from Gardner Denver, air treatment technology that came via acquisition post-merger. And then if you remember, we've done now 80-plus bolt-on transactions since the merger. Now not every one of them is necessarily applicable to this lens, but there have been a number that have, whether they be U.S., Western Europe, even India-based acquisitions that have differentiated technology that, that China team is probably -- they're probably the poster child internally in terms of being able to localize and localize with speed. And so they've done a really good job. And so even if you look, despite even some of the headwinds we've seen over the last few years, if you were to kind of go under the covers and look you'll actually see some nice growth in some of those differentiated technologies, albeit off a much lower baseline. And so I think we're encouraged by where that portfolio is at least positioned to continue to leverage some of those strengths in terms of differentiating technology. We'll still be in, I think, what we consider to be an industry leader on the compression side that we'll continue to see hopefully growth off of , albeit a reset baseline that we talked about for the last 2 years.

Stephen Volkmann

analyst
#20

Okay. And I think pricing has been a bit of a challenge. You mentioned low double-digit volume in terms of recent growth. Is that stabilizing?

Vikram Kini

executive
#21

Yes, I think the way we'd say it here and just maybe to give a little bit of color, I think we talked about this period in our second quarter earnings call. We always talked about this year after, I'd say, the pricing dynamics in the last few years with supply chain and tariffs that obviously drove an outsized pricing impact. We would expect the pricing to kind of refer back to that 1% to 2% level, which is pretty normal in this industry. And this is exactly where we are. Now it should be mentioned here that, that includes a negative low single-digit headwind from China specifically. Now I would say China, even historically has probably been a much more competitive pricing environment. I wouldn't say that even historically speaking, China was at the levels of North America or Western Europe or areas like that. But to your point, yes, I think just given some of the resets you've seen in the market, some of the capacity that's been in the market and things like that in a broader sense, not just naturally our technology, but broader sense, you have seen some more pricing headwinds we would view that as something that, over the medium term should moderate. Again, as things continue to normalize, as volumes continue to get healthier out there, we would expect that to get back to historic levels, but that's not going to be something that happens at overnight quarter. That's more of a 2027 onwards dynamic. So definitely something we're seeing right now but an area that we would expect to moderate and improve as we move over the course of the next number of quarters.

Stephen Volkmann

analyst
#22

Okay. Good. Maybe switching to EMEA, things have been a little more, I guess, volatile over there in terms of timing around lower vacuums and Middle East delays, et cetera. What's the outlook there?

Vikram Kini

executive
#23

Yes. So kind of to your point here, I think if you look over the last few years, me has actually probably been our most stable region comparatively speaking, right? So the way we kind of look at it is we have EMEA inclusive, so Europe as well as the Middle East, India and Africa. If you kind of look at the puts and takes, not surprisingly, I'd say India has been probably the best performing region of the entire company, obviously, not the biggest piece of the equation, but India has been a big kind of growth kind of region for us. In fact, we're pretty explicit. We actually opened a new second manufacturing plant from a compression technology perspective there late last year. And I think we continue to see good traction in the India front. Not surprisingly, areas like the Middle East. Middle East is approximately 3% to 4% revenue base, roughly speaking, obviously, impacted by what's going on here in the Middle East right now. I think if there's good use to be had here that is that hopefully, when we get a bit of a stability and things normalize there, we do feel that there's maybe some pent-up demand or whatnot from an Italy perspective. But that aside, Middle East and probably Central Europe have probably been on the other side of the equation from a headwind perspective. And then the balance of where we play is really in Western Europe, so areas like Italy, Spain, France, U.K. Nordics. And they've each had kind of a, I'd say, some of it a little bit better than others. The best way I can probably say it right now is, I would say, Europe is relatively neutral when you put those areas to kind of together, as we're -- kind of we're seeing right now with some of the puts and takes.

Stephen Volkmann

analyst
#24

Okay. And then we've already sort of talked about North America. But I'm curious, often, I think, identified as sort of 1 of the beneficiaries of reshoring, onshoring in North America. Can you specifically sort of say that you're seeing demand from that theme? .

Vikram Kini

executive
#25

Yes. I mean I think you're seeing an improvement in just broadening trends as we sit here right now. Have there been pockets of reshoring, onshoring that you've seen benefits from, yes. Would I point to that being the biggest catalyst or driver. I wouldn't necessarily say it's the biggest catalyst. So I think we continue to be encouraged by seeing what we're kind of some of these trends in these themes I think what you're seeing right now is just an improvement in kind of the overall kind of just demand environment. But to your point, yes, absolutely. To the degree there continues to be more onshore and reshoring type capabilities or opportunities this business tends to be a bit more CapEx driven in terms of compression technology and things like that. And that would be an area that we would expect to be a beneficiary from.

Stephen Volkmann

analyst
#26

Okay. Good. Let's talk a little bit about ITS margin. So they've been a little bit pressured, I guess, tariffs, volumes. China pricing, we talked about some of your commercial investments. But I think you are guiding a stronger second half. What gives you confidence in that?

Vikram Kini

executive
#27

Yes. So to your point here, ITS margins were in the upper 20s towards 30% that have kind of been more in the 26, 27-ish percent realm here. So still operating at a healthy level, especially in lieu of repeat them all the headwinds that you've kind of talked about over the last few years. And I think we do continue to be encouraged by, if you kind of look under the cover, continuing to see good momentum in areas like aftermarket recurring revenue that have at least I'd say, bolstered the margins, albeit not necessarily mitigating the full extent of the area you talked about. Now as far as going forward, whether it be second half of the year or barely into the next year, a couple of the areas that we feel like should be tailwinds to the margin equation. So a couple of things. One, we talked about the price cost dynamic starting, I'd say, normalized. And clearly, even in the first half of the year, we've taken certain targeted pricing actions, as you would expect, that we'd expect to deliver into the back half of the year. Probably the biggest one here and probably the barrier that's had the biggest headwind from the last 2 years is volumes, right? We've been in an environment for the last 2 years. That's really been absent of organic volume, particularly on the OE front. And if you think about our portfolio, again, whether it be ITS or even PST, these are both segments that play above 40% gross margin. And I would say, original equipment and aftermarket play at healthy levels. It's not like you have low-margin original equipment and its recent range might know, they're both very good margin profile businesses just as volumes continue to improve, that should help the margin front. The other pieces here that I would speak to in terms of just the margin progression within the business, a couple of things to think about. -- one, the productivity equation. So as a reminder, material is about 70% of our cost of goods sold -- and generally speaking, and this is not necessarily in the statement necessarily about 2026. You see this generally most year. If not is, is every year, your margin profile tends to be healthier in the back half of the year as part the first half of the year, if nothing else because of the seasonality factor. Typically speaking, ITS has revenue base lighter in first quarter, heaviest in Q4, Q2, Q3 in between and particularly as that cost of goods sold flows through in the back half of the year, you tend to see that productivity follow it. And the other piece here, you saw us talk pretty explicitly in the back half of last year into the first quarter of this year, about some targeted restructuring that we did kind of portfolio-wide. So it was total enterprise-wide, but ITS is 80% of the revenue of the business. So you can expect that was the biggest piece. That's largely been consumed by just time. So for all those factors, we would expect a healthier margin profile as we exit the back half of this year. And again, we'll wait to kind of guide on '27 and things like that. But for us, the biggest piece, that should be helping ITS margins as we move forward is price volume price cost aside here for a second, it's just getting back to, I'd say, a regular normalized volume cadence, which is the piece you really haven't seen in the last few years.

Stephen Volkmann

analyst
#28

Okay. Good. Let's switch to PST then. Life Sciences, I guess, has been sort of the highlight there. Orders running low double digits, mid-teens for several quarters now. Just talk about what's driving that and the bigger themes and whether they're sustainable?

Vikram Kini

executive
#29

Yes, for sure. Very encouraged about what we're seeing on the life sciences side. So we've talked about this for a few years that we created this life sciences platform by kind of the combination of the legacy, we just call it Gardner Denver, then the Ingersoll Red Medical business. Now we refer to it as our Flow Control Solutions business internally. That's the biggest piece, but then you also have the assets from ILC Dover that really are now creating a $600 million to $700 million life sciences platform that you really didn't have historically. And I think when you look at our exposures across the life sciences spectrum, whether it be the legacy IR Gardner ever medical business, which is selling more, what I'll call, compression and pump technology into medical lab life sciences, lab automation, diagnostic type equipment. The second largest business is the biopharma business for Myles Dover, which clearly has been the best growth business in the entire portfolio. exposed to and obviously making single-use powder containment technology for drug manufacturing. And then even the medical device business, which is the contract manufacturing business exposed to some good trends in neurology and cardiac type applications on a contract manufacturing basis. You're actually seeing good drivers of growth across all 3, albeit they're all exposed to slightly different at different aspects of the life sciences platform, the diet life sciences spectrum. So the way Steve would probably say it here is that, to your point, Life Sciences has been the best growth profile business of the entire equation. It's worth noting here that the pathogen technology side has also shown pretty good traction here as of late. These are businesses that both play a very healthy margin profiles. It's worth noting that now over the last 2 years, the Life Sciences business has definitely closed the gap towards the Precision Technologies, and you've seen that now in the overall PSD margins. where now this business has played above 30% for at least 3 or 4 now consecutive quarters. We're starting to alpine approach that mid-30s kind of EBITDA margin target that we've historically laid out. And I think our simple way to think about it is we don't expect that at least the levers or at least the growth drivers are seeing to dramatically change on the go forward. So I think we continue to be encouraged there. As far as the balance of whether it be pricing, whether productivity. I think a lot of those, you'll see us fairly similar themes and trends switches on the ITS side. Clearly, the volume side here has probably been a little bit quicker and more evident as of late, but again, continues to be quite healthy on the go forward.

Stephen Volkmann

analyst
#30

Okay. So to your point, you hit 35.5% EBITDA margin in the second quarter in PST, if my number right. And then you've described this mid-30s target. -- what do you need to do there operationally mix? What gets you to the mid-30s?

Vikram Kini

executive
#31

Yes. So I think we've kind of probably been in that 31%, 32% range, thereabouts. So again, to your point, not that far away from the mid-30s. I think it's just continued execution. I think a lot of the blocking and tackling in the context of, what I would call, the restructuring integration of the ILC over asset is behind us. that at had, it's been a little over 2, almost 2.5 years now since the acquisition. So I think now the structure, hardline P&L, you've really seen it adopt Rx demand gen, the same toolkit that you've seen about the rest of the spectrum. Now I think it's really just the blocking and tackling. So at that point, pricing will be comparable to what you see on the ITS front. The productivity equation is very much there. I think a lot of it just comes down to core volume growth. The other piece here that now is becoming a little bit more evident, particularly on the Life Sciences side, is the bolt-on M&A routine. We've now done 4 bolt-on acquisitions since the ILC Door acquisition into that Life Sciences business. We continue to do bolt-on acquisitions in the PT side of the equation, too. So I think it's just essentially a blocking and tackling and just continued volume growth. There's no reason that the margin profile that, that business plays out and the gross margin profile of 45% plus that you should continue to see good incrementals and could flow through there.

Stephen Volkmann

analyst
#32

Great. Okay. I'm going to come up for air for just a second. Does anybody here want to ask a question? We have a mic if you do -- and if you don't, I'll keep going. All right. No takers. So maybe we'll just finalize the margin discussion. Just how should we think about incrementals in the 2 segments sort of medium term?

Vikram Kini

executive
#33

Yes. I mean I think this business, we've historically said the business over the cycle or medium term, wants to play in that 30% to 40% realm with ITS probably lower end of that realm, a PST plays towards the higher end. I think that's the right way to target things over that kind of medium-term spectrum given some of the inputs and factors we've talked about. But as we've said a motor times, the volume piece of that equation is clearly the catalyst to kind of keeping in those ranges.

Stephen Volkmann

analyst
#34

Okay. Great. Recurring revenue and sort of attachment rates has been something you guys have been very focused on. I think you have a $1 billion target for recurring revenue up from what was it $450 last year.

Vikram Kini

executive
#35

$450 and not too long ago, back in 2021, the number was closer to $100 million. So yes, we've had quite a run here. It's clearly been probably the single biggest organic growth driver our focus from an initiative perspective internally. To your point here, this is a model that really kind of started in compressor side in North America, legacy Ingersoll Rand. I will still say compressors, North America is the biggest piece of the equation. But now really expanding that model on how do you drive multiyear contractually driven, the service or other type aftermarket contracts with your customer base to really kind of lock in that true recurring revenue base. And I think now what you've seen is the model really being adapted to the other regions, as well as kind of some of the Gardner Denver portfolio as well as some of the other product technologies that at least inherently historically, you maybe didn't think about it the same blower, vacuum pumps, areas that if they have a wrench attorney and service type applications and need, there may be something that can be applicable there. So you sit here today, to your point, yes, we eclipsed $450 million last year. obviously still plenty of room to run. We continue to be really excited about the opportunity set here. And now we actually kind of have measurable baselines and momentum across essentially the wide variety of the business, right? I will still say that the majority of what you're seeing is really on the direct side of the equation. So I think earlier this year, trying to take this model and adapted a little bit more through the channel and partnering with our channel partners, that's, I think, continued opportunity on the go forward. But I think we continue to be really excited about the opportunities at here. And this obviously is, I'd say, a healthy aftermarket margin business. So again, continuing to see traction. And this should hopefully be an area, I'd say, a lever over the medium to long term that should continue to bolster margins in the grand scheme of things.

Stephen Volkmann

analyst
#36

Great. Okay. So let's flip to M&A since you mentioned that a moment ago, obviously, of 400 to 500 basis points of growth is kind of your long-term target. I think you're about halfway through that this year. So what does the pipeline look like? Yes.

Vikram Kini

executive
#37

So I'd say pipeline continues to remain active and healthy. If we could flattish back here to our last earnings call, I think we mentioned that we still have over 200 active companies in the funnel at that time, 11 transactions under LOI. The way I'd describe it right now is these are very much of the bolt-on variety very similar the types of transactions you've seen announced over the last number of years, but even over the first half of the year. So again, kind of right down the middle of the fairway type of opportunities I think we have mentioned that there's always inherently maybe a slightly larger transaction that we've had or things like that. But, at this point in time, I'd say the funnel is largely of that smaller bolt-on variety. And I'd say conversations continue to be very fruitful and active. So to your point, yes, roughly about halfway to the target halfway through the year. So again, we continue to remain optimistic on over the medium term here, continuing to operate in that 400 to 500 basis point range is a good target for us. Nothing that we would say really is changing our viewpoint there. And I'd be -- I will note good traction on both sides of the equation, ITS and PST. So very similar to what you heard us said historically, and I think the funnel continues to be relatively healthy and robust.

Stephen Volkmann

analyst
#38

Okay. Great. All right. So we have about 2 minutes left. Is there anything I should have asked you or you think investors are not fully appreciating.

Vikram Kini

executive
#39

No, I think you've covered the big basis here and not to kind of -- to repeat myself from earlier, but I think the piece here that we -- after a couple of years of macro headwinds and things like that, that we continue to remain we're becoming, I'd say, more encouraged by is just the growth side of the equation, right? You've heard us talk pretty explicitly over the last number of even despite some of the headwinds we've seen that we're continuing to invest, whether it be in manufacturing site in areas like India or Brazil, whether it be commercial investments, wherever feet on the street, even in -- I think it was Q2, we announced a strategic partnership with a third party on some oil-free technology, which is really kind of R&D co-development. The common theme and trend amongst all these with some of the AI discussion we had earlier, this is all about driving sustainable organic growth for the longer term. And so we'll continue to invest in the company and the business to drive organic volume growth. I think we're encouraged to now starting to see end markets and the major regionally play in starting to be a little bit better than where you've seen in the last couple of years. And now it's really more so operationally in thereafter. So I think we remain encouraged here. And other than that, I think you covered the basis in the highlights.

Stephen Volkmann

analyst
#40

Very good. Well, I appreciate it as always. And thank you all for your attention.

Vikram Kini

executive
#41

Yes, thank you.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Ingersoll Rand Inc. transcript — plus 254,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Ingersoll Rand Inc. earnings transcripts and 254,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.